Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_provenance.
- NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_assertion description "[The present study suggests that none of the major genetic polymorphisms in the RAA system (angiotensinogen, angiotensin-converting enzyme, angiotensin II type 1 receptor, and aldosterone synthase) strongly influence the onset of essential hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_provenance.
- NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_assertion evidence source_evidence_literature NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_provenance.
- NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_assertion SIO_000772 17190732 NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_provenance.
- NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_assertion wasDerivedFrom lhgdn-20090331 NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_provenance.
- NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_assertion wasGeneratedBy ECO_0000203 NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_provenance.
- lhgdn-20090331 importedOn "2009-03-31" NP221689.RAhganO4aRFSkfSf337d1khil9bGeQLeQ--LQGpOc1osM130_provenance.